HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carla Isernia Selected Research
Carla Isernia Research Topics
Disease
2
Neoplasms (Cancer)
07/2019 - 12/2016
2
Neuroblastoma
10/2013 - 03/2011
1
COVID-19
03/2022
1
Insulin Resistance
12/2021
1
Infections
03/2020
1
Communicable Diseases (Infectious Diseases)
05/2019
1
Pathologic Processes
05/2019
1
Inflammation (Inflammations)
05/2019
1
Fibrosis (Cirrhosis)
05/2019
1
Breast Neoplasms (Breast Cancer)
12/2016
1
Carcinoma (Carcinomatosis)
12/2016
1
Colonic Neoplasms (Colon Cancer)
12/2016
1
Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2013
1
Urinary Tract Infections (Urinary Tract Infection)
06/2013
1
Neurodegenerative Diseases (Neurodegenerative Disease)
04/2013
1
Pathologic Neovascularization
04/2013
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
03/2022 - 03/2011
2
Antiviral Agents (Antivirals)
IBA
03/2022 - 03/2020
1
Glucose (Dextrose)
FDA Link
Generic
12/2021
1
Acyclovir (Aciclovir)
FDA Link
Generic
03/2020
1
Integrins
IBA
05/2019
1
Membrane Proteins (Integral Membrane Proteins)
IBA
05/2019
1
thiazolyl blue
IBA
12/2016
1
pyrimidine
IBA
12/2016
1
betadex (beta-cyclodextrin)
IBA
12/2016
1
Pharmaceutical Preparations
IBA
12/2016
1
Fluorouracil (Carac)
FDA Link
Generic
12/2016
1
Peptides (Polypeptides)
IBA
10/2013
1
Protein Isoforms (Isoforms)
IBA
09/2013
1
Glycoproteins (Glycoprotein)
IBA
09/2013
1
Pipemidic Acid (Palin)
IBA
06/2013
1
Ions
IBA
04/2013
1
Metals
IBA
04/2013
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
04/2013
Therapy/Procedure
1
Therapeutics
07/2019
1
Aftercare (After-Treatment)
03/2011